Rite Aid Corp. posted a slight gain in comparable-store sales for August. Rite Aid said Thursday that for the five weeks ended Aug. 29, same-store sales edged up 1.6% year over year. The increase continued the drug chain’s positive trend in comp-store sales for 2015 but was down from gains earlier
Sandoz has inaugurated a new era in medicine with the release of Zarxio, the first biosimilar of a biologic drug approved in the United States. The Novartis subsidiary said Thursday that Zarxio — a biosimilar of Amgen Corp.
Par Pharmaceutical has released testosterone gel 1%, a generic version of AndroGel 1% from AbbVie. Par said Wednesday that its testosterone gel 1% product is available in 2.5g and 5g aluminum foil packets containing 25 mg or 50 mg of testosterone, respectively.
CVS/pharmacy’s removal of tobacco products from its stores is showing its impact a year later. A study by the CVS Health Research Institute revealed a reduction in cigarette purchases over the past year, CVS Health said Thursday.
Lannett Co. plans to acquire Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic drug subsidiary of UCB S.A., in a $1.23 billion deal. Lannett said late Wednesday that the acquisition will add a diversified commercial product portfolio of 18 products.
Hershey Co. has made its Ice Breakers mints available via the Amazon Dash Button, a miniature device that makes it easier for consumers to reorder their favorite products.
Rite Aid Corp. chairman and chief executive officer John Standley recently explained how retail pharmacies can promote value-based care in an opinion piece for the Philadelphia Inquirer/Daily News on Philly.com.
If you weren’t able to get to the 2015 NACDS Total Store Expo in Denver, or were there and missed out on some of the happenings, NACDS-TV has provided a recap segment of the conference.
This month, Sam’s Club pharmacies plan to hold free diabetes screenings for club members and the public. The Walmart warehouse club chain said Wednesday that the screenings, to be offered on Sept.
Sandoz has launched a rivastigmine patch, a treatment for dementia, in the U.S. market. The Novartis subsidiary said Wednesday that its rivastigmine transdermal system is an authorized generic version of the Exelon patch, marketed by Novartis Pharmaceuticals Corp.
Walgreens and the United Nations Foundation have kicked off their annual “Get a Shot, Give a Shot” campaign, which aims to provide life-saving vaccines where they’re most needed to children worldwide.
Sundial Brands, the maker of natural beauty care brands SheaMoisture and Nubian Heritage, has sold a minority interest in the company to global investment firm Bain Capital Private Equity.
J M Smith Corp. has acquired pharmacy-related technology products and services offered by Integra NV and will manage them as a subsidiary called Integra LTC Solutions LLC.
Frank Segrave, president and chief executive officer of Silvergate Pharmaceuticals and former vice president of pharmacy at Walmart, has joined the board of directors of Bartell Drugs.
Sanofi and the life sciences team at Google have formed a collaboration to improve care and outcomes for people with type 1 and type 2 diabetes.
Biosimilars offer tremendous promise for millions of Americans suffering from cancer, rheumatoid arthritis or other diseases, offering lower-cost and highly effective alternatives to costly reference product drugs, also known as biologics.
